Eagle's Eye View: Day 3 Highlights | ACC.19
In this special episode of Eagle’s Eye View, Dr. Peter Block, Dr. Kim Eagle, and Dr. Deepak Bhatt discuss highlights from Day 3 of ACC.19, including IRAD: Acute Aortic Dissection: Lessons Learned From 9000 Patients, REDUCE-IT: Reduction in Total Ischemic Events With Icosapent Ethyl, DECLARE-TIMI 58 HFrEF: Dapagliflozin on HF and Mortality in T2D Based on EF, and SAFARI-STEMI: Femoral Access vs. Radial Access For Primary PCI in STEMI.
Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Hypertriglyceridemia, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Acute Heart Failure, Interventions and ACS, Hypertension, Smoking
Keywords: ACC Annual Scientific Session, ACC19, EaglesEyeView, Amputation, Atherosclerosis, Diabetic Ketoacidosis, Diabetes Mellitus, Type 2, Brain Ischemia, Dyslipidemias, Heart Failure, Hemoglobin A, Glycosylated, Hyperglycemia, Hypertension, Metabolic Syndrome X, Myocardial Ischemia, Myocardial Infarction, Primary Prevention, Renal Insufficiency, Chronic, Stroke, Stroke Volume, Smoking, Vascular Diseases, Benzhydryl Compounds, Angina, Unstable, Atrial Fibrillation, Cholesterol, HDL, Cholesterol, LDL, Diabetes Mellitus, Eicosapentaenoic Acid, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertriglyceridemia, Myocardial Revascularization, Triglycerides, Secondary Prevention, Acute Coronary Syndrome, Aspirin, Heparin, Medical Futility, Peptide Fragments, Percutaneous Coronary Intervention, Stents, Thrombosis, Vascular Closure Devices
< Back to Listings